Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
Nature Reports Stem Cells
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Genetics  8, 399 - 404 (1994)
doi:10.1038/ng1294-399

Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

Lori S. Friedman1, Elizabeth A. Ostermeyer1, Csilla I. Szabo1, Patrick Dowd1, Eric D. Lynch1, Sarah E. Rowell1 & Mary-Claire King1

1Department of Molecular & Cell Biology and School of Public Health, University of California, Berkeley, California 94720, USA

We provide genetic evidence supporting the identity of the candidate gene for BRCA1 through the characterization of germline mutations in 63 breast cancer patients and 10 ovarian cancer patients in ten families with cancer linked to chromosome 17q21. Nine different mutations were detected by screening BRCA1 DNA and RNA by single-strand conformation polymorphism analysis and direct sequencing. Seven mutations lead to protein truncations at sites throughout the gene. One missense mutation (which occurred independently in two families) leads to loss of a cysteine in the zinc binding domain. An intronic single basepair substitution destroys an acceptor site and activates a cryptic splice site, leading to a 59 basepair insertion and chain termination. The four families wrth both breast and ovarian cancer had chain termination mutations in the N-terminal half of the protein.

REFERENCES
  1. Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66−71 (1994).
  2. Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684−1689 (1990).
  3. Albertsen, H.M. et al. A physical map and candidate genes in the BRCA1 region on chromosome 17q12−21. Nature Genet. 7, 472−479 (1994).
  4. Sharp, P.A. Split genes and RNA splicing. Cell 77, 805−815. (1994).
  5. Friedman, L.S. et al. The search for BRCA1 and the cloning of 22 genes from chromosome 17q21. Cancer Res. (in the press).
  6. American Society of Human Genetics. Statement on genetic testing for breast and ovarian cancer. Am. J. hum. Genet. 55, 860 (1994).
  7. Rowell, S., Newman, B., Boyd, J. & King, M-C. Inherited predisposition to breast and ovarian cancer. Am. J. hum. Genet. 55, 861−865 (1994).
  8. Arena, J.F. et al. Inherited breast cancer: Confirmation of linkage to BRCA2, possible linkage to the estrogen receptor, and the clinical implications of genetic complexity. J. Am. med. Assoc. (in the press).
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1994 Nature Publishing Group | Privacy policy